Dylan Bram  Crotty net worth and biography

Dylan Crotty Biography and Net Worth

Group President, Orthopaedics of Stryker

Dylan Crotty became Group President, Orthopaedics in January 2026.

Dylan oversees our Joint Replacement, Trauma & Extremities and Ortho Tech Businesses.

In his previous role as President, Instruments, Dylan oversaw Orthopaedic Instruments, Surgical Technologies, Neurosurgical, Craniomaxillofacial, Interventional Spine and ENT.

Dylan began his career with Stryker in 1999 and has held a series of senior leadership positions including Vice President and General Manager roles in Surgical, Neuro Spine and ENT, and Foot & Ankle. Earlier in his career, he served as Managing Director for Stryker UK, Ireland, South Africa and General Manager of Trauma and Craniomaxillofacial across Europe.

Dylan serves on the Board of StacheStrong, supporting research and initiatives dedicated to combating brain cancer.

He holds a bachelor's degree in business administration from Hope College and has served on multiple healthcare and nonprofit boards in southwest Michigan.

What is Dylan Bram Crotty's net worth?

The estimated net worth of Dylan Bram Crotty is at least $2.01 million as of August 21st, 2026. Mr. Crotty owns 6,102 shares of Stryker stock worth more than $2,014,148 as of August 27th. This net worth approximation does not reflect any other assets that Mr. Crotty may own. Learn More about Dylan Bram Crotty's net worth.

How do I contact Dylan Bram Crotty?

The corporate mailing address for Mr. Crotty and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Dylan Bram Crotty's contact information.

Has Dylan Bram Crotty been buying or selling shares of Stryker?

Within the last three months, Dylan Bram Crotty has sold $144,917.01 in shares of Stryker stock. Most recently, Dylan Bram Crotty sold 441 shares of the business's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a transaction totalling $144,917.01. Following the completion of the sale, the insider now directly owns 6,102 shares of the company's stock, valued at $2,005,178.22. Learn More on Dylan Bram Crotty's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Dylan Crotty (Group President, Orthopaedics), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Debra King (Vice President, Chief Digital and Information Officer), Kevin Lobo (Chair and CEO), Viju Menon (Group President, Global Quality and Operations), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), Ronda Stryker (Director), and Preston Wells (Vice President, Chief Financial Officer). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 13 times. They sold a total of 1,446,649 shares worth more than $494,969,122.16. The most recent insider tranaction occured on August, 21st when insider Dylan Bram Crotty sold 441 shares worth more than $144,917.01. Insiders at Stryker own 4.6% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 8/21/2026.

Dylan Bram Crotty Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2026Sell441$328.61$144,917.016,102View SEC Filing Icon  
See Full Table

Dylan Bram Crotty Buying and Selling Activity at Stryker

This chart shows Dylan Bram Crotty's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $324.27
Low: $327.00
High: $327.00

50 Day Range

MA: $328.37
Low: $304.64
High: $352.35

2 Week Range

Now: $324.27
Low: $281.00
High: $396.86

Volume

905 shs

Average Volume

2,350,156 shs

Market Capitalization

$124.38 billion

P/E Ratio

33.65

Dividend Yield

1.06%

Beta

0.76